(Q35088780)

English

Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

mucopolysaccharidosis I

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

9

object named as

Joleen T White

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Charles H Vite

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ping Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Reema T Patel

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Raquel M Walton

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Steven U Walkley

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Rani S Sellers

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

N Matthew Ellinwood

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Alphonsus S Cheng

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Charles A O'Neill

10

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mark Haskins

11

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Molecular Genetics and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

268-274

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

Mucopolysaccharidosis I: management and treatment guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

Intrathecal enzyme replacement therapy: successful treatment of brain disease via the cerebrospinal fluid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

Laronidase treatment of mucopolysaccharidosis I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

Enzyme replacement in a canine model of Hurler syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

The pathology of the feline model of mucopolysaccharidosis I

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

Mucopolysaccharide Storage Disease in Three Families of Cats with Arylsulfatase B Deficiency: Leukocyte Studies and Carrier Identification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

8 July 2018

A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

27 September 2018

Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

27 September 2018

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

27 September 2018

Enzyme replacement therapy in feline mucopolysaccharidosis I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

27 September 2018

Enzyme-replacement therapy in mucopolysaccharidosis I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3130519

27 September 2018

Spinal problems in mucopolysaccharidosis I (Hurler syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.03.011

7 January 2021

Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.03.011

7 January 2021

Intrathecal enzyme replacement therapy in a patient with mucopolysaccharidosis type I and symptomatic spinal cord compression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.03.011

7 January 2021

Mucopolysaccharidosis: thickening of dura mater at the craniocervical junction and other CT/MRI findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2011.03.011

7 January 2021

Hydrocephalus in Maroteaux-Lamy syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21482164

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YMGME.2011.03.011

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35088780&oldid=2144111418"